OSTEOMED ORTHODONTIC ANCHOR PLATING SYSTEM
Device Facts
| Record ID | K051798 |
|---|---|
| Device Name | OSTEOMED ORTHODONTIC ANCHOR PLATING SYSTEM |
| Applicant | Osteomed LP |
| Product Code | DZE · Dental |
| Decision Date | Apr 7, 2006 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3640 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
Intended to be surgically placed in the mouth for use as an anchor for orthodontic procedures. It is used temporarily and is removed after orthodontic treatment has been completed. Plates, screws, and pilot drills are intended for single use only.
Device Story
OsteoMed Orthodontic Anchor Plating System consists of metal plates and Auto-Drive screws; surgically implanted in mouth to provide temporary skeletal anchorage for orthodontic procedures; removed after treatment completion. System provides various shapes/sizes to accommodate anatomical requirements; fixed to bone via screws. Used by clinicians in dental/orthodontic settings. Device serves as stable anchor point to facilitate tooth movement; benefits patient by providing reliable anchorage for complex orthodontic corrections.
Clinical Evidence
No clinical data; bench testing only.
Technological Characteristics
System includes plates, Auto-Drive screws, and pilot drills. Single-use components. Mechanical fixation to bone. No software or electronic components.
Indications for Use
Indicated for patients requiring temporary orthodontic anchorage. Surgically placed in the mouth to serve as an anchor for orthodontic procedures; removed upon completion of treatment.
Regulatory Classification
Identification
An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.
Special Controls
*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.